Avanos Medical Stock Price, News & Analysis (NYSE:AVNS)

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical Inc (NYSE:AVNS) released its quarterly earnings results on Tuesday, August, 6th. The company reported $0.28 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.25 by $0.03. The firm earned $172.20 million during the quarter, compared to analyst estimates of $172.02 million. Avanos Medical had a positive return on equity of 4.18% and a negative net margin of 3.92%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.20 EPS. View Avanos Medical's Earnings History.

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Avanos Medical.

Avanos Medical issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of $1.15-1.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.23.

6 brokers have issued twelve-month price targets for Avanos Medical's shares. Their predictions range from $45.00 to $69.00. On average, they anticipate Avanos Medical's stock price to reach $54.80 in the next year. This suggests a possible upside of 47.2% from the stock's current price. View Analyst Price Targets for Avanos Medical.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

Press coverage about AVNS stock has been trending negative recently, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Avanos Medical earned a daily sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Avanos Medical.

Avanos Medical saw a decrease in short interest in the month of August. As of August 31st, there was short interest totalling 2,579,400 shares, a decrease of 6.7% from the July 31st total of 2,763,300 shares. Based on an average trading volume of 286,600 shares, the days-to-cover ratio is currently 9.0 days. Currently, 5.5% of the company's shares are sold short. View Avanos Medical's Current Options Chain.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX), ConforMIS (CFMS), Lakeland Industries (LAKE), Rewalk Robotics (RWLK), Histogenics (HSGX), Precision Therapeutics (POAI), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV) and Wound Management Technologies (WNDM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Honeywell International (HON), CVS Health (CVS), AlarmCom (ALRM), IHS Markit (INFO), Workday (WDAY), Baxter International (BAX), Kimberly Clark (KMB), Nike (NKE), Veeva Systems (VEEV) and Westinghouse Air Brake Technologies (WAB).

Avanos Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.46%), BlackRock Inc. (11.46%), Price T Rowe Associates Inc. MD (10.32%), Vanguard Group Inc. (9.44%), Victory Capital Management Inc. (4.80%) and Paradice Investment Management LLC (4.19%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Chicago Equity Partners LLC, Eagle Asset Management Inc., Bank of New York Mellon Corp, Vanguard Group Inc., Morgan Stanley, Price T Rowe Associates Inc. MD and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Avanos Medical.

AVNS stock was acquired by a variety of institutional investors in the last quarter, including RGM Capital LLC, Paradice Investment Management LLC, Invesco Ltd., Nuveen Asset Management LLC, Marshall Wace LLP, Confluence Investment Management LLC, Victory Capital Management Inc. and Northern Trust Corp. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $37.23.

Avanos Medical has a market capitalization of $1.78 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

The official website for Avanos Medical is http://www.halyardhealth.com/.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]